ABVX Abivax Total Asset Value of Company
ABIVAX maintains high margins driven by unique patents and cutting-edge technologies. This chart on GURU.Markets shows that total assets are fixed at 334.45. The company achieves cost optimization by outsourcing production and testing to third-party contractors. Looking ahead, FDA approval for colitis drugs will grant ABIVAX monopoly status and a massive cash flow with minimal production costs.
Analytical breakdowns and data insights for company Abivax (ABVX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio ABIVAX|ABVX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Abivax SA|ABVX - Company Aggregate Debts|Debts to Book Capitalization Abivax Corp|ABVX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Abivax|Interim Coverage Ratio abivax.com
- net income and valuation multiples indicators:
Fundamental valuation:ABIVAX
Total assets, reverse-calculated via ROA, reflect the aggregate volume of resources and capital available to ABIVAX (ABVX) for profit generation. An analysis of the asset and resource calculations for ABIVAX (ABVX) demonstrates the financial foundation for diversifying the development of anti-inflammatory immune drugs, where the stability of the trend confirms the issuer's ability to scale expansion into colitis and arthritis therapy markets without liquidity risk.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|ADMA Biologics Inc - Total Asset Value of Company|Company Total Assets PTGX|IMVT (Immunovant Therapeutics) - Aggregate Asset Value|Company Total Assets KNSA (Kiniksa Pharmaceuticals)|Company Total Assets grifols.com GRFS|ADPT - Aggregate Company Assets|Aggregate Asset Value CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|ANAB - Company Total Assets|ATXS: Company Total Assets|ENGN (engene.com) - Aggregate Company Assets|RAPT (RAPT Therapeutics) - Company Total Assets|Aerovate (JBIO) - Company Total Asset Base|Cumulative Company Assets ACRS (Aclaris)|Aggregate Company Assets KYTX (Kyverna Therapeutics, Inc)|Company Total Assets TLSA (Tiziana Life Sciences)|Company Total Assets cabalettabio.com CABA|VTYX: Cumulative Company Assets|THTX (Theratechnologies, Inc.) - Total Business Assets|AVTX: Company Total Assets|Eledon Pharmaceuticals, Inc (ELDN) - Company Total Assets|AGEN (Agenus) - Company Total Assets|Aggregate Company Assets CLYM|Cumulative Company Assets ZURA (Zura Bio)|Aggregate Company Assets ATYR (aTyr Pharma Inc)|Adagene Inc. - Cumulative Company Assets|IMA: Total Business Assets|STTK - Aggregate Company Assets|Total Asset Value of Company EQ|CNTB: Company Total Assets|Immunic - Aggregate Asset Value|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Company Total Assets InflaRx GmbH|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|ACET (adicetbio.com) - Aggregate Asset Value|Aggregate Company Assets Celularity CELU|INMB - Cumulative Company Assets|Barinthus Bio - Company Total Assets|KZR - Company Total Assets|SABS (SAB Biotherapeutics) - Cumulative Company Assets|akaritx.com - Aggregate Asset Value|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Q32 Bio Corp (QTTB) - Company Total Asset Base|Aggregate Company Assets GeoVax Labs Inc (GOVX)|Cumulative Company Assets Edesa Biotech Corp EDSA|Aggregate Company Assets iBio, Inc. IBIO|CARM - Cumulative Company Assets|XTLB: Cumulative Company Assets|BOLT - Company Total Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|Total Business Assets APVO|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Assets Aditxt Corp ADTX|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|Revelation Biosciences Corp - Aggregate Company Assets|Indaptus Therapeutics - Company Total Assets|Company Total Asset Base scinai.com SCNI|CALI (calcimedica.com) - Cumulative Company Assets|AFMD (Affimed N.V.) - Aggregate Company Assets|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Cumulative Company Assets IGMS (IGM Biosciences, Inc.)|iteostherapeutics.com - Total Business Assets|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc - Company Total Assets